Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor

H Vaisocherová, H Šípová, I Víšová, M Bocková… - Biosensors and …, 2015 - Elsevier
H Vaisocherová, H Šípová, I Víšová, M Bocková, T Špringer, ML Ermini, X Song, Z Krejčík…
Biosensors and Bioelectronics, 2015Elsevier
We report an ultra-low fouling surface plasmon resonance imaging (SPRi) biosensor for the
rapid simultaneous detection of multiple miRNAs in erythrocyte lysate (EL) at subpicomolar
levels without need of RNA extraction. The SPRi chips were coated with ultra-low fouling
functionalizable poly (carboxybetaine acrylamide)(pCBAA) brushes having optimized
thicknesses and directly functionalized with amino-modified oligonucleotide probes. We
have characterized the effect of the brush thickness on the probe loading capacity: a loading …
Abstract
We report an ultra-low fouling surface plasmon resonance imaging (SPRi) biosensor for the rapid simultaneous detection of multiple miRNAs in erythrocyte lysate (EL) at subpicomolar levels without need of RNA extraction. The SPRi chips were coated with ultra-low fouling functionalizable poly(carboxybetaine acrylamide) (pCBAA) brushes having optimized thicknesses and directly functionalized with amino-modified oligonucleotide probes. We have characterized the effect of the brush thickness on the probe loading capacity: a loading capacity of ~9.8×1012 probes/cm2 was achieved for pCBAA having a thickness of ~40 nm. The probe-functionalized sensor also exhibited a high resistance to fouling from ~90% EL samples (<2 ng/cm2). A two-step detection assay was employed for multiplexed miRNA detection in EL. Specifically, the assay consisted of (i) a sandwich-type hybridization of the probe-functionalized pCBAA with target miRNA in EL (bound to biotinylated oligonucleotides) and (ii) the capture of streptavidin-functionalized gold nanoparticles to the aforementioned biotinylated probes. We have demonstrated that this approach enables the detection of miRNAs in EL at concentrations as low as 0.5 pM. Finally, we have confirmed the detection of four endogenous miRNAs representing a set of potential miRNA biomarkers of myelodysplastic syndrome (MDS) in clinical EL samples (miR-16, miR-181, miR-34a, and miR-125b). The results revealed significantly higher levels of miR-16 in all the clinical EL samples compared to the other measured miRNAs.
Elsevier